IQVIA Unveils Advanced AI Agents for Enhanced Life Sciences and Healthcare Solutions

IQVIA, a leading provider of clinical research services, has introduced custom-built AI agents at GTC Paris, using NVIDIA technology to enhance workflows in the life sciences sector. These AI agents aim to streamline operations and boost insights throughout the asset life cycle, addressing the unique needs of life sciences companies. According to Bhavik Patel, president of IQVIA Commercial Solutions, this collaboration signifies a step toward smarter healthcare, combining deep expertise with powerful technologies. The agents are designed for various applications, such as target identification and clinical data review, with the goal of improving efficiency in clinical trials. As NVIDIA’s Kimberly Powell noted, the combination of domain-specific agents can significantly benefit researchers. IQVIA’s commitment to responsible AI practices prioritizes privacy and compliance, aiming to enhance patient outcomes via actionable insights. A conference, IQVIA TechIQ 2025, will further explore advancements in AI for the industry.

Source link